The IL-1 system in HIV infection: peripheral concentrations of IL-1β, IL-1 receptor antagonist and soluble IL-1 receptor type II

Por KREUZER, K-A, DAYER, J-M, ROCKSTROH, JK, SAUERBRUCH, T, SPENGLER, U
Publicado em 1997

Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?

Por Anadol, E, Kaiser, R, Verheyen, J, Schülter, E, Emmelkamp, J, Schwarze-Zander, C, Kupfer, B, Wasmuth, JC, Rockstroh, JK
Publicado em 2010

Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the IL28B gene

Por Lutz, P, Wasmuth, J-C, Nischalke, H-D, Vidovic, N, Grünhagei, F, Lammert, F, Oldenburg, J, Rockstroh, JK, Sauerbruch, T, Spcngler, U
Publicado em 2011

GB Virus C (GBV-C) coinfection in advanced HIV disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T cells

Por Schwarze-Zander, C, Neibecker, M, Othman, S, Tural, C, Clotet, B, Blackard, JT, Kupfer, B, Luechters, G, Chung, RT, Rockstroh, JK, Spengler, U
Publicado em 2010

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence

Por Vogel, M, Friedrich, O, Lüchters, G, Holleczek, B, Wasmuth, JC, Anadol, E, Schwarze-Zander, C, Nattermann, J, Oldenburg, J, Sauerbruch, T, Rockstroh, JK, Spengler, U
Publicado em 2011

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*

Por Grint, D, Peters, L, Schwarze-Zander, C, Beniowski, M, Pradier, C, Battegay, M, Jevtovic, D, Soriano, V, Lundgren, JD, Rockstroh, JK, Kirk, O, Mocroft, A
Publicado em 2013

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals

Por Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK
Publicado em 2010-03-01

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals

Por Vogel, M, Ahlenstiel, G, Hintsche, B, Fenske, S, Trein, A, Lutz, T, Schürmann, D, Stephan, C, Khaykin, P, Bickel, M, Mayr, C, Baumgarten, A, Buggisch, P, Klinker, H, John, C, Gölz, J, Staszewski, S, Rockstroh, JK
Publicado em 2010